Kexing Biopharm Co., Ltd.

SHSE:688136 Stock Report

Market Cap: CN¥3.9b

Kexing Biopharm Management

Management criteria checks 3/4

Kexing Biopharm's CEO is Yanqing Zhao, appointed in Jul 2019, has a tenure of 5.42 years. directly owns 0.039% of the company’s shares, worth CN¥1.50M. The average tenure of the management team and the board of directors is 5.4 years and 5.4 years respectively.

Key information

Yanqing Zhao

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentagen/a
CEO tenure5.4yrs
CEO ownership0.04%
Management average tenure5.4yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

There's No Escaping Kexing Biopharm Co., Ltd.'s (SHSE:688136) Muted Revenues Despite A 36% Share Price Rise

Oct 08
There's No Escaping Kexing Biopharm Co., Ltd.'s (SHSE:688136) Muted Revenues Despite A 36% Share Price Rise

Kexing Biopharm Co., Ltd.'s (SHSE:688136) Share Price Boosted 36% But Its Business Prospects Need A Lift Too

May 21
Kexing Biopharm Co., Ltd.'s (SHSE:688136) Share Price Boosted 36% But Its Business Prospects Need A Lift Too

Shandong Kexing Bioproducts Co,.Ltd (SHSE:688136) Held Back By Insufficient Growth Even After Shares Climb 25%

Mar 08
Shandong Kexing Bioproducts Co,.Ltd (SHSE:688136) Held Back By Insufficient Growth Even After Shares Climb 25%

CEO

Yanqing Zhao (42 yo)

5.4yrs

Tenure

CN¥1,070,600

Compensation

Mr. Yanqing Zhao is MD & Director of Kexing Biopharm Co. Ltd. from July 29, 2019.

Leadership Team

NamePositionTenureCompensationOwnership
Yanqing Zhao
MD & Director5.4yrsCN¥1.07m0.039%
CN¥ 1.5m
Xiaoqin Wang
Head of Accounting5.4yrsCN¥742.40k0.020%
CN¥ 771.2k
Ning Cui
Deputy GM & Director5.4yrsCN¥692.50k0.016%
CN¥ 632.7k
Suofu Qin
Deputy General Managerno dataCN¥1.30m0.023%
CN¥ 887.6k
Ke Shao
Deputy General Managerno dataCN¥1.80m0.041%
CN¥ 1.6m
Hongjie Ma
Deputy General Manager5.4yrsCN¥844.10k0.018%
CN¥ 684.1k

5.4yrs

Average Tenure

50yo

Average Age

Experienced Management: 688136's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yanqing Zhao
MD & Director5.4yrsCN¥1.07m0.039%
CN¥ 1.5m
Ning Cui
Deputy GM & Director5.4yrsCN¥692.50k0.016%
CN¥ 632.7k
An Tang
Independent Director5.4yrsCN¥180.00kno data
Xueqin Deng
Chairman of the Board5.4yrsno data67.68%
CN¥ 2.6b
Jianhong Tao
Independent Director5.4yrsCN¥180.00kno data
Die Li
Employee Representative Supervisor2.4yrsno datano data
Wei Liu
Supervisor1.3yrsno datano data

5.4yrs

Average Tenure

47yo

Average Age

Experienced Board: 688136's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 06:08
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kexing Biopharm Co., Ltd. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kai WangCitic Securities Co., Ltd.
Yin YePing An Securities Co. Ltd.
Song YangTianfeng Securities Brokerage Co., Ltd